Actionable news
0
All posts from Actionable news
Actionable news in AZN: ASTRAZENECA PLC,

Stifel Comments On Relypsa M&A Rumors: 'Timing Could Be Tricky'

Trade with confidence. Are you a professional trader? Be the first to get the alert with Benzinga Pro's real-time newsfeed and audio squawk and never miss an opportunity again.
Don't miss the chance to try it FREE today.

RLYP, Astrazeneca PLC NYSE:AZN - Stifel Comments On Relypsa M&A Rumors: 'Timing Could Be Tricky'

Shares of Relypsa Inc RLYP 67.61% gained 67.61 percent on Thursday on renewed rumors of a possible buyout. According to Reuters, the company has hired an advisory firm, responding to “a number of overtures from potential buyers.”

On Thursday afternoon, analysts at Stifel said “the price movement is expected given the >40% short interest (per Bloomberg) currently outstanding on the name – short interest that has largely manifested as a result of financing concerns (FY16 OpEx...


More